Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project

Salma Malik   ^{1 *} , PharmB, PhD ;   Zoi Pana Dorothea   ^{2 *} , MD, MSc, PhD ;   Christos D Argyropoulos   ^{3 *} , MSci, MSc, PhD ;   Sophia Themistocleous   ^{2 *} , MSc ;   Alan J Macken   ^{4 *} , MSc ;   Olena Valdenmaiier   ^{5 *} , MSc ;   Frank Scheckenbach   ^{6 *} , PhD ;   Elena Bardach   ^{6 *} , MSc ;   Andrea Pfeiffer   ^{6 *} , MS ;   Katherine Loens   ^{7 *} , PhD ;   Jordi Cano Ochando   ^{8 *} , PhD ;   Oliver A Cornely   ^{9 *} , MD, PhD ;   Jacques Demotes-Mainard   ^{1 *} , MBA, MD, PhD ;   Sergio Contrino   ^{1 *} , ING ;   Gerd Felder   ^{1 *}

¹ European Clinical Research Infrastructure Network, Paris, France

² School of Medicine, European University Cyprus, Nicosia, Cyprus

³ Chemical Engineering Department, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia

⁴ Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland

⁵ Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

⁶ Clinical Trials Centre Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany

⁷ Laboratory of Medical Microbiology, VAXINFECTIO, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium

⁸ Microbiology Section, Department of Pharmaceutical Sciences and of Health, Faculty of Pharmacy, Universidad San Pablo-Centro de Estudios Universitarios, Madrid, Spain

⁹ University of Cologne, Faculty of Medicine and University Hospital Cologne, CECAD,CIO ABCD, ECMM,CMMC, Cologne, Germany

*all authors contributed equally